Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Yulin Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development and manufacture of Traditional Chinese Medicine (TCM). Founded in 1956 and headquartered in Yulin, Guangxi, the company became a key subsidiary of China Resources Pharmaceutical Group in 2010. It is best known for its flagship orthopedic products, particularly Zheng Gu Shui, which is widely used for treating bone fractures, sprains, and muscle pain. The company's portfolio also includes treatments for hepatobiliary health, rheumatism, and various dermatological conditions. Operating with modern GMP-certified facilities, the company exports its products to over 30 countries and regions, maintaining a strong reputation in both domestic and international herbal medicine markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yulin Huaran Pharmaceutical.